dallas semaglutide pancreatitis class action Acute due to different regimens: An updated meta-analysis A newly approved 7.2-mg dose

NewsHealth Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get The days of cheaper alternatives to popular weight-loss drugs like Wegovy and Zepbound are over for some Long Islanders and are numbered for others, pharmacists and compounding industry groups say

Future BPC-157 Research BPC-157 is under active investigation in a number of cell culture and animal models

Dual activation of GLP-1 and GIP receptors may increase nausea risk during initial titration but does not introduce new serious adverse events beyond those documented for single agents

At Centra Internal Medicine, we dont just hand you a prescription